tm logo
EFESA
FORMALIZED

on 13 Mar 2024

Last Applicant/ Owned by

GENEXINE INC.

(Magokdong, Bio Innovation Park) 172,Magokjungang-ro,Gangseo-guSeoul 07789

KR

Serial Number

2315495 filed on 22nd Dec 2023

EFESA

Trademark usage description

pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical agents affecting metabolism; cardiovascular treatmen Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical agents affecting metabolism; cardiovascular treatment preparations; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the treatment of kidney disorders; pharmaceutical preparations for the treatment of kidney diseases; pharmaceutical preparations for the treatment of diseases of the metabolic system; pharmaceutical preparations for the treatment of cardiovascular disease; medicines for the treatment of cardiovascular and cerebrovascular diseases; pills for dizziness symptoms treatment; biological preparations for medical purposes; cardiovascular agents for medical purposes; drugs for medical purposes; synthetic peptides for pharmaceutical purposes; pharmaceuticals; medicines for human purposes; anemia treatment medicines that stimulate red blood cell production; medicines to stimulate red blood cell production; medicines for treatment of chronic kidney disease and anemia; biological preparations for treatment of anemia; biological preparations to stimulate red blood cell production for veterinary and medical purposes; synthetic peptides for pharmaceutical and anemia treatment purposes; synthetic peptides for pharmaceutical and kidney disease treatment purposes.


Classification kind code

12

Mark Details


Serial Number

2315495

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 257
on 14th Mar 2024
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 13th Mar 2024
Created
Submitted for opposition 31
on 13th Mar 2024
Formalized
Submitted for opposition 228
on 22nd Dec 2023
International Registration
Submitted for opposition 30
on 22nd Dec 2023
Filed